While launching a pharmaceutical product is never a cake walk, launching a drug within a chronic disease space presents its own unique challenges. How can emerging pharma companies target a market that’s already well established and compete against the bigger players?
For Aerie Pharmaceuticals, which focuses on addressing the unmet needs of patients suffering from glaucoma and other conditions of the eye, part of the answer was superior data and analytics supported by an advanced technology solution. Here’s how the company leveraged REVO Analytics to empower its sales reps and more effectively engage its customer base ahead of two key product launches.
GET THE CASE STUDY
Copyright 2019 Industry Dive
Form submitted successfully.
Thank you for your interest in the case study! Click below to get your copy.